Ankur Saini, MD
Sleep Medicine · Omaha, NENPI 1144529397
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,145 of the $3,185 with a category attached, or 67.3%. 24 manufacturers reported payments, led by ZOLL Respicardia, Inc. at 40.6% of the total.
Across 79 payments — averaging $40.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Respicardia, Inc.$1K
- AstraZeneca$613
- Jazz Pharmaceuticals Inc.$381
- Harmony Biosciences LLC$322
- Inspire Medical Systems, Inc.$105
- Merck$56
- plus $416 from 18 others
What the payments were for
- Travel & lodging$87127%
- Food & beverage$2,14567%
- Education$1705%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few sleep medicine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Bupropion XlBupropion Hcl | 23 | $458 |
| Atorvastatin Calcium | 34 | $435 |
| Lubiprostone | 13 | $435 |
| Furosemide | 18 | $112 |
| Metformin Hcl | 23 | $104 |
| Amlodipine Besylate | 21 | $88 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Omaha
- Naresh DewanOmaha$5K
- John HarringtonOmaha$3K
- Stephanie WongOmaha$3K
- Minky SainiOmaha$2K
- Matthew DennisOmaha$584
- Michael SummersOmaha$237
- Mark WilsonOmaha$119
- Jefrey StartNorth Platte$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.